2020
DOI: 10.1124/dmd.119.088674
|View full text |Cite
|
Sign up to set email alerts
|

The Impact of Breast Cancer Resistance Protein (BCRP/ABCG2) on Drug Transport Across Caco-2 Cell Monolayers

Abstract: The impact of breast cancer resistant protein (BCRP/ABCG2) on drug transport across Caco-2 cell monolayers

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

1
17
0
3

Year Published

2021
2021
2024
2024

Publication Types

Select...
6
1

Relationship

1
6

Authors

Journals

citations
Cited by 23 publications
(21 citation statements)
references
References 49 publications
1
17
0
3
Order By: Relevance
“…Caco-2 cells from Dainippon Sumitomo Pharma (Osaka, Japan) were cultured in DMEM supplemented with 10% heat-inactivated fetal bovine serum, 1% antibiotic-antimycotic, 1% nonessential amino acids, and 2 mM L-glutamine [31]. Cells were maintained at 37 • C in 5% CO 2 /95% air and passaged upon reaching approximately 80% confluence using 0.25% trypsin/1 mM EDTA solution.…”
Section: Cell Culturementioning
confidence: 99%
See 1 more Smart Citation
“…Caco-2 cells from Dainippon Sumitomo Pharma (Osaka, Japan) were cultured in DMEM supplemented with 10% heat-inactivated fetal bovine serum, 1% antibiotic-antimycotic, 1% nonessential amino acids, and 2 mM L-glutamine [31]. Cells were maintained at 37 • C in 5% CO 2 /95% air and passaged upon reaching approximately 80% confluence using 0.25% trypsin/1 mM EDTA solution.…”
Section: Cell Culturementioning
confidence: 99%
“…The apical-to-basal (AP-to-BL) P app value (P app,AB ) (•), and basal-to-apical (BL-to-AP) P app value (P app,BA ) ( ) values were determined by the AP-to-BL and BL-to-AP transport of paclitaxel in Caco-2 cells in the presence or absence of various concentrations of P-gp inhibitors. The P app,BA values of paclitaxel in the presence of GF120918, LY335979, and WK-X-34 were cited from our previous report [31]. Data are represented as mean ± S.D.…”
Section: Inhibitory Effect Of P-gp Inhibitors On the Transport Of Paclitaxel In Caco-2 Cellsmentioning
confidence: 99%
“…There are three kinds of variability of DT abundances: (1) organism-specific expressions (Durmus et al, 2015), (2) tissue-differential distributions (Nixon et al, 2016) and ( 3) disease-dependent abundances (Evers et al, 2018). As provided in Table 2, the tissue-differential distribution data have been provided by multiple databases, such as TTD, PharmGKB, UCSF-FDA TransPortal, Metrabase and VARIDT, which further demonstrate the critical roles of such variability in drug disposition (Kawahara et al, 2020). For the remaining two kinds of variability data, VARIDT is the only knowledge base of such information, and the differential expression patterns are provided for 108 diseases and 3 model organisms.…”
Section: Diverse Data Illustrating Various Aspects Of Dt Variabilitymentioning
confidence: 99%
“…Membrane transporters play critical roles in discovering new drugs and elucidating disease mechanisms (Nigam, 2018), which can be divided into channels, carriers, electron flow carriers, group translocators, and pumps for determining the molecular composition and energy state of cells (Cook et al, 2014;Saier et al, 2021). The identified drug uptake/efflux transporters may constitute only a small fraction of all these general transporters, but these general transporters are of great importance for elucidating drug metabolism (Wang et al, 2020b) and disposition (Kawahara et al, 2020). Thus, the databases available for describing general transporters and transporter families are valuable treasures for current DT research.…”
Section: Databases Describing Transporters and Transporter Familiesmentioning
confidence: 99%
See 1 more Smart Citation